Earnings call transcript: Flerie Q3 2026 NAV slips as biotech write-downs weigh

Earnings call transcript: Flerie Q3 2026 NAV slips as biotech write-downs weigh....
Key Takeaways
- Earnings call transcript: Flerie Q3 2026 NAV slips as biotech write-downs weigh.
Read Complete Original Article
Published originally on Investing.com
Related News

US lawmakers unveil bill to hold Wall Street’s ‘Epstein-connected’ bosses to account
Move comes as Senator Elizabeth Warren condemns Barclays response to questions over ex-boss’s ties to sex offender US lawmakers have unveiled a new bill to hold Wall Street’s “Epstein-connected” bosses to account for helping finance the late sex offender’s crimes. It came as top Democratic senator Elizabeth Warren condemned the UK bank Barclays for “dodging responsibility” over its failure to vet former boss Jes Staley and his ties to the once well-connected billionaire. Continue reading...

US jobless claims steady at 199,000, gold prices hold above $4,100 amid inflation concerns - Pluang
US jobless claims steady at 199,000, gold prices hold above $4,100 amid inflation concerns Pluang

Truist cuts Atmos Energy stock price target on steady outlook
Truist cuts Atmos Energy stock price target on steady outlook....

KeyBanc cuts Rocket Lab stock price target on Neutron delay
KeyBanc cuts Rocket Lab stock price target on Neutron delay....

